Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adaptor related protein complex 1 subunit sigma 2 (AP1S2) encodes the small sigma-2 subunit of the clathrin-associated adaptor protein complex 1 (AP-1). The AP-1 complex regulates vesicle formation and protein sorting at the trans-Golgi network and endosomes by recognizing sorting signals in transmembrane proteins and recruiting clathrin to the membrane surface[1][3]. It is essential for proper cell function, particularly in neurons, and disruption of its function via mutation can cause syndromic X-linked mental retardation and related neurodevelopmental disorders such as Pettigrew syndrome[1][2][7]. AP1S2 is not considered a classical therapeutic target but is implicated in the molecular machinery that governs protein sorting and vesicular trafficking in human cells.
Null. No established drugs target AP1S2 directly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adaptor related protein complex 1 subunit sigma 2 (AP1S2).